v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash $ 177,384 $ 509,914
Pre-payment 3,551
Total current assets 177,384 513,465
Intangibles, net 156,009 145,087
Total assets 333,393 658,552
Current liabilities:    
Accounts payable and accrued expenses 1,198,685 824,278
Loan from affiliates 355,598 395,668
Other short-term loans 50,000 50,000
Derivative Liability 369,730 403,353
Convertible notes payable, net of premium and discount 805,000 805,000
Total current liabilities 5,274,697 3,249,894
Total liabilities 5,274,697 3,249,894
Commitments and contingencies
Stockholders’ deficit:    
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 43,283,991 issued and outstanding as at June 30, 2026, and December 31, 2025 43,284 43,284
Common stock, $0.001 par value; 400,000,000 shares authorized; 114,695,220 and 108,147,731 issued and outstanding as at June 30, 2026, and December 31, 2025, respectively 114,695 108,148
Additional paid-in capital 18,633,881 18,301,472
Accumulated deficit (23,733,164) (21,044,246)
Total stockholders’ deficit (4,941,304) (2,591,342)
Total liabilities and stockholders’ equity 333,393 658,552
Related Party [Member]    
Current liabilities:    
Accounts payable affiliates 1,076,876 673,317
Un-issued shares liability [1] 1,360,606 82,006
Loan from affiliates [2] 355,598 395,668
Nonrelated Party [Member]    
Current liabilities:    
Un-issued shares liability $ 58,202 $ 16,272
[1] As of June 30, 2026, the amount to be converted into shares of Preferred Stock is $1,360,606. This consist of $82,006 is to our Directors for their attendance at board and committee meetings during the fourth quarter and $1,278,600 to Dr. Platt as a performance grant in recognition of his role in executing the Company’s first commercial distribution agreement and advancing capital funding initiatives. On December 31, 2025 this amount was $82,006.
[2] On June 30, 2026, the Company has a $355,598 loan from an affiliated company with an interest rate of 8%. The accrued interest is currently $75,761. On December 31, 2025, the Company the loan was $395,668 and the accrued interest $52,459.